astrazeneca glp 1 pipeline AstraZeneca's elecoglipron just posted some of the most closely watched Phase IIb data of the year and it landed at the right conference. Results from the VISTA and SOLSTICE trials, published simultaneously Pipeline - AstraZeneca

Weve all heard that stopping taking a GLP-1 medication for weight losssuch as semaglutide (marketed as Wegovy) and tirzepatide (sold as Zepbound)often leads to rapid weight gain, with people returning to baseline in as little as 18 months

By combining data from observational and Mendelian randomization (MR) studies, we aimed to investigate whether GLP-1 RAs decrease the risk of DR

Jan 31, 2026 Realistic week-by-week timeline for your first 6 months on GLP-1 medications: Week 1-2 (appetite drops, 2-5 lbs lost), Month 1 (food thoughts quiet, 4-8 lbs), Month 2 (finding rhythm, 8-15 lbs), Month 3 (visible changes, 12-20 lbs), Month 4-5 (steady progress, 18-30 lbs), Month 6 (milestone

Are TikTok-viral yerba mate powders the same as real yerba mate

Many patients report less joint and neuropathic pain on GLP-1 therapy

Methods Tests included several chromatography methods coupled with ultraviolet and mass spectrometry detectors, inductively coupled plasma optical emission spectroscopy, inductively coupled plasma mass spectrometry, nuclear magnetic resonance, dissolution analyses, in silico peptide/major histocompatibility complex II-binding prediction, and fibrillation assays